Skip to content
★ Sign in to follow
DG

Daniel Gannon

Shareholder
Dnaprint Genomics Inc
Total declarations
34
Company
1
▲ Purchases (34 ops.)
€39k
▼ Sales (0 ops.)
—

Latest filing published 13 Jan 2009 for DNAPRINT GENOMICS INC, €134.

Insider track record

Disclosed buys
34
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
34
Positive at T+90
29%
Median T+90
+0.0%

Based on 34 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Daniel Gannon: trading record in brief

All filings by Daniel Gannon on record concern Dnaprint Genomics Inc. Over a trading history stretching from 7 October 2008 to 6 January 2009, the count stands at 34 filings.

The open-market record is one-sided, with 34 purchases worth €39k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2009 to date brings 5 purchases and no sales.

A typical purchase (the median) is worth €234. Looking at 34 purchases old enough to measure, the stock rose over the following 90 days in 29% of cases; the median change was +0.0%. They describe history only and say nothing certain about the share price ahead.

On 13 January 2009 came the latest disclosure, an open-market purchase for €134 in Dnaprint Genomics Inc. Typically, a trade is published a median of 7 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Daniel Gannon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    186 USD0SEC
    465,274 shares@ US$0.0004Common StockSEC:0001443865-09-000003:0
    Canonical exit: 2 Apr 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    205 USD0SEC
    513,000 shares@ US$0.0004Common StockSEC:0001443865-09-000003:1
    Canonical exit: 6 Apr 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    9 USD0SEC
    21,475 shares@ US$0.0004Common StockSEC:0001443865-09-000001:0
    Canonical exit: 29 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    61 USD0SEC
    153,350 shares@ US$0.0004Common StockSEC:0001443865-09-000001:1
    Canonical exit: 30 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    275 USD0SEC
    686,802 shares@ US$0.0004Common StockSEC:0001443865-09-000001:2
    Canonical exit: 31 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    30 USD0SEC
    98,900 shares@ US$0.0003Common StockSEC:0001443865-08-000015:0
    Canonical exit: 22 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    1,108 USD0SEC
    2,771,177 shares@ US$0.0004Common StockSEC:0001443865-08-000015:1
    Canonical exit: 22 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    468 USD0SEC
    1,169,700 shares@ US$0.0004Common StockSEC:0001443865-08-000015:2
    Canonical exit: 23 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    531 USD0SEC
    1,328,000 shares@ US$0.0004Common StockSEC:0001443865-08-000015:3
    Canonical exit: 26 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    46 USD0SEC
    114,387 shares@ US$0.0004Common StockSEC:0001443865-08-000014:0
    Canonical exit: 15 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    1,210 USD0SEC
    3,024,000 shares@ US$0.0004Common StockSEC:0001443865-08-000014:1
    Canonical exit: 16 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    340 USD0SEC
    849,475 shares@ US$0.0004Common StockSEC:0001443865-08-000014:2
    Canonical exit: 17 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    104 USD0SEC
    258,880 shares@ US$0.0004Common StockSEC:0001443865-08-000014:3
    Canonical exit: 18 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    260 USD0SEC
    650,000 shares@ US$0.0004Common StockSEC:0001443865-08-000014:4
    Canonical exit: 19 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    1,691 USD0SEC
    4,227,658 shares@ US$0.0004Common StockSEC:0001443865-08-000012:0
    Canonical exit: 11 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    28 USD0SEC
    70,925 shares@ US$0.0004Common StockSEC:0001443865-08-000012:1
    Canonical exit: 12 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    400 USD0SEC
    1,000,000 shares@ US$0.0004Common StockSEC:0001443865-08-000011:0
    Canonical exit: 3 Mar 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    0 USD0SEC
    500 shares@ US$0.0004Common StockSEC:0001443865-08-000010:0
    Canonical exit: 19 Feb 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    71 USD0SEC
    177,000 shares@ US$0.0004Common StockSEC:0001443865-08-000010:1
    Canonical exit: 23 Feb 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    37 USD0SEC
    92,000 shares@ US$0.0004Common StockSEC:0001443865-08-000009:0
    Canonical exit: 9 Feb 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    8 USD0SEC
    20,000 shares@ US$0.0004Common StockSEC:0001443865-08-000009:1
    Canonical exit: 11 Feb 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    5,783 USD0SEC
    14,457,175 shares@ US$0.0004Common StockSEC:0001443865-08-000009:2
    Canonical exit: 17 Feb 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    307 USD0SEC
    768,322 shares@ US$0.0004Common StockSEC:0001443865-08-000009:3
    Canonical exit: 18 Feb 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    6,148 USD0SEC
    15,371,035 shares@ US$0.0004Common StockSEC:0001443865-08-000006:0
    Canonical exit: 28 Jan 2009 (T+90)
  • ▲
    10% OwnerExecutivesDnaprint Genomics Inc
    8,638 USD0SEC
    21,595,000 shares@ US$0.0004Common StockSEC:0001443865-08-000006:1
    Canonical exit: 29 Jan 2009 (T+90)

25 of 34 declarations